Clinical trial · Observational
A Study to Explore the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients
A Prospective Observational Study to the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients
NCT06118229CI-TRIAL-00078374unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The trial was designed as a single-center non-interventional prospective observational study to explore the role and impact of wearable smart devices in perioperative NSCLC patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non Small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Wearable smart devices and PROs | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- NSCLC patients wearing wearable smart devices
- description
- NSCLC patients wearing wearable smart devices while utilizing PROs for regular follow-up
- interventionNames
- Device: Wearable smart devices and PROs
Primary outcomes (1)
- measure
- Postoperative length of hospital stay
- timeFrame
- From time of surgery to time of discharge from the hospital (assessed up to 30 days)
- description
- Postoperative Length of Stay (LOS) refers to the duration of a patient's hospitalization following surgery, typically measured from the completion of the surgical procedure to the time of patient discharge.
Secondary outcomes (1)
- measure
- Operative time
- timeFrame
- From time of the start of surgery to the end of surgery
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Participants must provide voluntary consent to participate in this research and possess the capacity to sign an informed consent form. 2. Participants must be aged over 18 years. 3. Participants must have undergone pulmonary resection surgery with a postoperative pathological confirmation of primary lung cancer. Exclusion Criteria: 1. Patient refusal to participate in this research. 2. Inability to wear wearable smart monitoring devices due to various reasons. 3. The pathological report suggests a non-small cell lung cancer (NSCLC) exclusion. 4. History of secondary lung cancer surgery.
References
Publications (0)
Data not yet available
No reference posted for this study.